Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.

Literature DB >> 16305581

Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed.

L Aarons.

Abstract

Mesh：

Year: 2005 PMID： 16305581 PMCID： PMC1884881 DOI： 10.1111/j.1365-2125.2005.02560.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

17 in total

1. A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery.

Authors: P Poulin; F P Theil
Journal: J Pharm Sci Date: 2000-01 Impact factor: 3.534

Review 2. A new approach to decoding life: systems biology.

Authors: T Ideker; T Galitski; L Hood
Journal: Annu Rev Genomics Hum Genet Date: 2001 Impact factor: 8.929

3. Population pharmacokinetics: theory and practice.

Authors: L Aarons
Journal: Br J Clin Pharmacol Date: 1991-12 Impact factor: 4.335

Review 4. A review of the applications of physiologically based pharmacokinetic modeling.

Authors: K J Himmelstein; R J Lutz
Journal: J Pharmacokinet Biopharm Date: 1979-04

5. Clearance concepts in pharmacokinetics.

Authors: M Rowland; L Z Benet; G G Graham
Journal: J Pharmacokinet Biopharm Date: 1973-04

6. Methotrexate pharmacokinetics.

Authors: K B Bischoff; R L Dedrick; D S Zaharko; J A Longstreth
Journal: J Pharm Sci Date: 1971-08 Impact factor: 3.534

7. Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model.

Authors: N Benowitz; F P Forsyth; K L Melmon; M Rowland
Journal: Clin Pharmacol Ther Date: 1974-07 Impact factor: 6.875

8. Physiologically based modelling of inhibition of metabolism and assessment of the relative potency of drug and metabolite: dextromethorphan vs. dextrorphan using quinidine inhibition.

Authors: A A Moghadamnia; A Rostami-Hodjegan; R Abdul-Manap; C E Wright; A H Morice; G T Tucker
Journal: Br J Clin Pharmacol Date: 2003-07 Impact factor: 4.335

9. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride.

Authors: M E Andersen; H J Clewell; M L Gargas; F A Smith; R H Reitz
Journal: Toxicol Appl Pharmacol Date: 1987-02 Impact factor: 4.219

10. Receptor-mediated pharmacodynamics of prednisolone in the rat.

Authors: F D Boudinot; R D'Ambrosio; W J Jusko
Journal: J Pharmacokinet Biopharm Date: 1986-10

22 in total

1. Cancer pharmacotherapy: 21st century 'magic bullets' and changing paradigms.

Authors: L D Lewis
Journal: Br J Clin Pharmacol Date: 2006-07 Impact factor: 4.335

2. From pharmacology to immunopharmacology.

Authors: Adam Cohen
Journal: Br J Clin Pharmacol Date: 2006-10 Impact factor: 4.335

Review 3. Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data.

Authors: Nikolaos Tsamandouras; Amin Rostami-Hodjegan; Leon Aarons
Journal: Br J Clin Pharmacol Date: 2015-01 Impact factor: 4.335

Review 4. Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposure.

Authors: Jong Hwan Sung; Balaji Srinivasan; Mandy Brigitte Esch; William T McLamb; Catia Bernabini; Michael L Shuler; James J Hickman
Journal: Exp Biol Med (Maywood) Date: 2014-06-20